| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $154K | -43.7% | +14.3% |
| SG&A Expense | $155K | -3.2% | +211.5% |
| Operating Income | -$925K | +16.9% | -130.5% |
| Pre-tax Income | $2.2M | +354.3% | +360.0% |
| Net Income | $2.2M | +354.3% | +360.0% |
| EPS (Basic) | $1.14 | +342.6% | +812.5% |
| EPS (Diluted) | $1.14 | +342.6% | +812.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $1K | -0.1% | — |
| Current Assets | $2.3M | -19.6% | +22.1% |
| Total Assets | $4.4M | -11.4% | +126.5% |
| Current Liabilities | $6.8M | -29.7% | +623.8% |
| Total Liabilities | $6.8M | -29.7% | +623.8% |
| Stockholders' Equity | -$2.4M | +49.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | — |
| Investing Cash Flow | $943K | — | — |
| Financing Cash Flow | $4.4M | — | — |
| -336.2% |